- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT00602732
Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse
Intervention for Low-income Pregnant Women With Partner Abuse
Přehled studie
Postavení
Podmínky
Detailní popis
Each year, approximately 324,000 pregnant women experience partner abuse (PA). With the emotional highs and lows that accompany new motherhood, pregnancy is often a challenging process for many women. Experiencing PA, while already going through a vulnerable time during pregnancy, may have harmful effects on the well-being of the woman and her infant. Women affected by PA are at an increased risk for certain physical and psychological problems, including depression and post-traumatic stress disorder (PTSD). Furthermore, the emotional distress from PA may impair a woman's ability to seek out the necessary support to ensure the safety of herself and her children. There have been few research efforts to develop an effective treatment to reduce the psychological impact of PA on pregnant women and even fewer efforts that target low-income women, who make up a large portion of affected women. The Reach Out for a Safe Environment (ROSE) program is an interpersonally oriented treatment developed to address factors that may contribute to postpartum mental health difficulties associated with PA. This study will evaluate the effectiveness of the ROSE program in preventing depression and PTSD in low-income pregnant women who have experienced recent PA.
Participation in this single-blind study will last approximately 29 weeks. All potential participants will answer an initial questionnaire concerning their history of physical, sexual, or emotional abuse in the past year. Selected participants will then undergo an interview about symptoms of depression, reactions to trauma, emotional difficulties, and alcohol and drug use. Participants invited to continue in the study will then be randomly assigned to the ROSE program or enhanced care as usual (ECU). Participants assigned to the ROSE program will attend four weekly 90-minute group sessions prior to delivery and one individual 50-minute booster session within 4 weeks of delivery. During these sessions, participants will learn ways to manage stress and negative feelings and how to access helpful resources. Participants will also complete two questionnaires about emotional difficulties per week for the duration of the program. Participants assigned to ECU will receive the usual medical care provided for pregnant women and will receive educational material on depression.
All participants will complete questionnaires and interviews about their emotional difficulties, relationships with others, and use of services for these difficulties prior to treatment assignment, 4 weeks after treatment assignment, 4 weeks after delivery, and 3 months after delivery. Participants in the ROSE program will additionally complete a questionnaire about their perceptions of the program after the fourth treatment session and after the booster session.
Typ studie
Zápis (Aktuální)
Fáze
- Fáze 1
Kontakty a umístění
Studijní místa
-
-
Rhode Island
-
Providence, Rhode Island, Spojené státy, 02905
- Memorial Hospital
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Able to speak and read English sufficiently to complete the study procedures
- Willing and able to receive public assistance
- Identified as having experienced physical assault based on responses to CTS2 within 1 year prior to study entry
- 35 weeks or less gestation
Exclusion Criteria:
- Meets current criteria for major depressive disorder or post-traumatic stress disorder
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: 1
Participants assigned to the ROSE program
|
Participants in the ROSE program will receive a course on managing stress and negative feelings and will learn how to access resources for help.
The ROSE program involves four 90-minute group sessions over a 4-week period prior to delivery.
Participants will also attend one 50-minute booster session within 4 weeks prior to delivery of their babies.
Ostatní jména:
|
|
Aktivní komparátor: 2
Participants assigned to enhanced care as usual
|
Participants in ECU will receive the usual medical care provided for pregnant women at their prenatal clinic.
Participants will also receive educational material and a list of treatment resources for depression.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Longitudinal Interval Follow-up Examination (LIFE)
Časové okno: Measured at Year 1
|
Measured at Year 1
|
Sekundární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Revised Conflict Tactic Scale (CTS2)
Časové okno: Measured at Year 1
|
Measured at Year 1
|
|
Edinburgh Postnatal Depression Scale
Časové okno: Measured at Year 1
|
Measured at Year 1
|
|
The Davidson Trauma Scale
Časové okno: Measured at Year 1
|
Measured at Year 1
|
|
The Arizona Social Support Interview Schedule
Časové okno: Measured at Year 1
|
Measured at Year 1
|
|
Parenting Stress Index
Časové okno: Measured at Year 1
|
Measured at Year 1
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Caron Zlotnick, PhD, Butler Hospital
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- R34MH075013 (Grant/smlouva NIH USA)
- DSIR 83-ATP (NCT00719979)
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .